{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:48:36Z","timestamp":1790434116930,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.semnephrol.2008.03.003","type":"journal-article","created":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T18:46:05Z","timestamp":1213037165000},"page":"306-317","source":"Crossref","is-referenced-by-count":45,"title":["Vasopressin Antagonists in Polycystic Kidney Disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Vicente E.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2008.03.003_bib1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpeds.2006.03.014","article-title":"Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a First National Institutes of Health\/Office of Rare Diseases conference","volume":"149","author":"Gunay-Aygun","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/4.4.575","article-title":"Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat","volume":"4","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0695-151","article-title":"The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains","volume":"10","author":"Hughes","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90339-9","article-title":"Polycystic kidney disease: the complete structure of the PKD1 gene and its protein","volume":"81","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/geno.2002.6802","article-title":"A novel gene encoding a TIG multiple domain protein is a positional candidate for autosomal recessive polycystic kidney disease","volume":"80","author":"Xiong","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng0697-179","article-title":"PKD1 interacts with PKD2 through a probable coiled-coil domain","volume":"16","author":"Qian","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib11","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1073\/pnas.94.13.6965","article-title":"Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2","volume":"94","author":"Tsiokas","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib12","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/MCB.00072-07","article-title":"Fibrocystin\/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.embor.7400745","article-title":"The versatile nature of the calcium-permeable cation channel TRPP2","volume":"7","author":"Giamarchi","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib14","series-title":"The kidney","first-page":"2283","article-title":"Autosomal dominant polycystic kidney disease and inherited cystic disease","author":"Somlo","year":"2007"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0925-4439(00)00079-X","article-title":"Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation","volume":"1535","author":"Geng","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI5111","article-title":"Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins","volume":"104","author":"Huan","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1091\/mbc.E03-05-0296","article-title":"A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells","volume":"15","author":"Roitbak","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI21753","article-title":"Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus","volume":"114","author":"Chauvet","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","article-title":"Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease","volume":"10","author":"Low","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib21","doi-asserted-by":"crossref","first-page":"34357","DOI":"10.1074\/jbc.M606740200","article-title":"Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C","volume":"281","author":"Hiesberger","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/hmg\/ddm039","article-title":"Polyductin undergoes notch-like processing and regulated release from primary cilia","volume":"16","author":"Kaimori","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib23","doi-asserted-by":"crossref","first-page":"R378","DOI":"10.1016\/S0960-9822(02)00877-1","article-title":"Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease","volume":"12","author":"Pazour","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib24","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/hmg\/ddg274","article-title":"Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia","volume":"12","author":"Ward","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib25","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(03)00511-7","article-title":"Two populations of node monocilia initiate left-right asymmetry in the mouse","volume":"114","author":"McGrath","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00232-001-0075-4","article-title":"Bending the MDCK cell primary cilium increases intracellular calcium","volume":"184","author":"Praetorius","year":"2001","journal-title":"J Membr Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib29","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1073\/pnas.0610324104","article-title":"Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2","volume":"104","author":"Anyatonwu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb754","article-title":"Polycystin-2 is an intracellular calcium release channel","volume":"4","author":"Koulen","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib31","doi-asserted-by":"crossref","first-page":"41298","DOI":"10.1074\/jbc.M510082200","article-title":"Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib32","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1073\/pnas.96.7.3934","article-title":"Specific association of the gene product of PKD2 with the TRPC1 channel","volume":"96","author":"Tsiokas","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib33","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/hmg\/ddg190","article-title":"Pkd2 haploinsufficiency alters intracellular calcium in vascular smooth muscle cells","volume":"12","author":"Qian","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.5483\/BMBRep.2007.40.4.467","article-title":"PKHD1 gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease","volume":"40","author":"Yang","year":"2007","journal-title":"J Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib35","doi-asserted-by":"crossref","first-page":"19264","DOI":"10.1074\/jbc.271.32.19264","article-title":"Localization of mRNAs encoding Ca2+-inhibitable adenylyl cyclases along the renal tubule","volume":"271","author":"Chabardes","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1523-1755.1999.00233.x","article-title":"Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney","volume":"55","author":"Dousa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1042\/bst0311186","article-title":"The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways","volume":"31","author":"Houslay","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib38","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib40","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib42","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib44","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib46","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib47","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0700499104","article-title":"Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease","volume":"104","author":"Leuenroth","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib48","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease","volume":"32","author":"O'Sullivan","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib49","first-page":"529","article-title":"Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis","volume":"19","author":"Xu","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib50","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1523-1755.2004.00967.x","article-title":"The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib51","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na(+),K(+),2Cl(\u2212) Co-transporter-dependent cystic dilation","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib52","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1523-1755.2003.00256.x","article-title":"EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats","volume":"64","author":"Torres","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib53","first-page":"225A","article-title":"Inhibition of ErbB2 decreases c-SRC activity and ameliorates renal and biliary cystic abnormalities in the PCK rat","volume":"16","author":"Sweeney","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib54","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2353\/ajpath.2006.051136","article-title":"Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib","volume":"169","author":"Sato","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib55","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1523-1755.2004.00952.x","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats","volume":"66","author":"Torres","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib56","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature05348","article-title":"Long lasting arrest of murine polycystic kidney disease with CDK inhibitor R-Roscovitine","volume":"444","author":"Bukanov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib57","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib58","first-page":"778A","article-title":"Inhibition in autosomal dominant polycystic kidney disease (ADPKD)","volume":"17","author":"Sweeney","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib60","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib61","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","article-title":"Vasopressin antagonists in polycystic kidney disease","volume":"68","author":"Torres","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib62","doi-asserted-by":"crossref","first-page":"F1166","DOI":"10.1152\/ajprenal.00196.2007","article-title":"Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL","volume":"293","author":"Mutig","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib63","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","article-title":"Regulation of cAMP production in initial and terminal inner medullary collecting ducts","volume":"54","author":"Yasuda","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib64","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(01)00328-5","article-title":"Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects","volume":"51","author":"Bankir","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib65","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/hmg\/10.23.2637","article-title":"Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome","volume":"10","author":"Liu","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jez.a.309","article-title":"Contribution of comparative fish studies to general endocrinology: structure and function of some osmoregulatory hormones","volume":"305","author":"Takei","year":"2006","journal-title":"J Exp Zoolog A Comp Exp Biol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib67","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1523-1755.2001.060002680.x","article-title":"\u201cAvian-type\u201d renal medullary tubule organization causes immaturity of urine-concentrating ability in neonates","volume":"60","author":"Liu","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib68","doi-asserted-by":"crossref","first-page":"F811","DOI":"10.1152\/ajprenal.00351.2003","article-title":"Kidneys sans glomeruli","volume":"286","author":"Beyenbach","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.0954-6820.1986.tb03330.x","article-title":"Expansion of extracellular volume in early polycystic kidney disease","volume":"219","author":"Danielsen","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib70","first-page":"329","article-title":"[The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease.]","volume":"96","author":"Michalski","year":"1996","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib71","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib72","first-page":"F169","article-title":"Expression of aquaporins-1 and \u22122 during nephrogenesis and in autosomal dominant polycystic kidney disease","volume":"271","author":"Devuyst","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib73","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1677\/joe.0.1730023","article-title":"Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene","volume":"173","author":"Yokoi","year":"2002","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib75","doi-asserted-by":"crossref","first-page":"F1418","DOI":"10.1152\/ajprenal.00358.2006","article-title":"Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway","volume":"292","author":"Izumi","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)36848-X","article-title":"V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs","volume":"282","author":"Bernat","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00003495-200767060-00002","article-title":"Therapeutic potential of vasopressin receptor antagonists","volume":"67","author":"Ali","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib78","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","article-title":"Vasopressin receptor antagonists","volume":"69","author":"Greenberg","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib79","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib80","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib81","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib82","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib83","doi-asserted-by":"crossref","first-page":"361A","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of OPC-41061 on polycystic kidney disease development in Pkd2WS25\/-","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib84","first-page":"138A","article-title":"Efficacy of OPC-41061 in the treatment of murine nephronophthisis","volume":"16","author":"Gattone","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib85","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in the PCK rat","volume":"19","author":"Wang","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib86","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ki.1985.152","article-title":"Selective ADH-induced hypertrophy of the medullary thick ascending limb in Brattleboro rats","volume":"28","author":"Bouby","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00583730","article-title":"Adaptation of the rat kidney to altered water intake and urine concentration","volume":"412","author":"Bankir","year":"1988","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib89","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib90","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1681\/ASN.2006090994","article-title":"Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease","volume":"18","author":"Chang","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib91","doi-asserted-by":"crossref","first-page":"F457","DOI":"10.1152\/ajprenal.2001.280.3.F457","article-title":"Segmental expression of somatostatin receptor subtypes sst(1) and sst(2) in tubules and glomeruli of human kidney","volume":"280","author":"Balster","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib92","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ki.1988.31","article-title":"Reversal of somatostatin inhibition of AVP-induced cAMP by pertussis toxin","volume":"33","author":"Ishikawa","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib93","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/cs0840455","article-title":"Somatostatin as a modulator of distal nephron water permeability","volume":"84","author":"Ray","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib94","first-page":"F951","article-title":"Endothelin-1 inhibits AVP-stimulated osmotic water permeability in rat inner medullary collecting duct","volume":"261","author":"Oishi","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib95","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0272-6386(03)00193-8","article-title":"High urine volume and low urine osmolality are risk factors for faster progression of renal disease","volume":"41","author":"Hebert","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib96","first-page":"R1420","article-title":"Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure","volume":"275","author":"Cowley","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib97","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/en.143.7.2759","article-title":"Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension","volume":"143","author":"Fernandes","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib98","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/hy1001.092641","article-title":"Chronic exposure to vasopressin upregulates ENaC and sodium transport in the rat renal collecting duct and lung","volume":"38","author":"Nicco","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib99","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/sj.ki.5000211","article-title":"Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system","volume":"69","author":"Sauter","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/01.HYP.35.3.740","article-title":"Nitric oxide in the renal medulla protects from vasopressin-induced hypertension","volume":"35","author":"Szentivanyi","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib101","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib102","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","article-title":"Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease","volume":"64","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ki.1991.36","article-title":"Osmoregulation of thirst and vasopressin release in severe chronic renal failure","volume":"39","author":"Argent","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib104","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V451091","article-title":"Is the process of urinary urea concentration responsible for a high glomerular filtration rate?","volume":"4","author":"Bankir","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/18.3.497","article-title":"Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system","volume":"18","author":"Bardoux","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib106","first-page":"F973","article-title":"Effect of water intake on the progression of chronic renal failure in the 5\/6 nephrectomized rat","volume":"258","author":"Bouby","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib107","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0024-3205(99)00330-6","article-title":"Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats","volume":"65","author":"Bouby","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib108","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1046\/j.1523-1755.1999.00443.x","article-title":"High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: possible role of TGF-b","volume":"55","author":"Sugiura","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib109","first-page":"68A","article-title":"A phase IIB pilot study of the safety and efficacy of tolvaptan, a vasopressin V2 receptor antagonist (V2RA) in patents with ADPKD","volume":"16","author":"Chapman","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib110","first-page":"361A","article-title":"Acute and chronic osmostasis after vassopressin V2 receptor inhibition with Tolvaptan in ADPKD","volume":"16","author":"Grantham","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib111","first-page":"361A","article-title":"Urine aquaporin 2 and cyclic AMP responses to tolvaptan administration in autosomal dominant polycystic kidney disease","volume":"16","author":"Torres","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2008.03.003_bib112","first-page":"F1166","article-title":"Phase 2 open-label study to determine safety, tolerability and efficacy of split-dose Tolvaptan in ADPKD","volume":"293","author":"Torres","year":"2007","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929508000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929508000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T17:13:18Z","timestamp":1738257198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929508000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0270929508000508"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2008.03.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}